Identification of shared gene signatures and biological mechanisms between preeclampsia and polycystic ovary syndrome

Yaoxi Xiong; Chao Chen; Chengrong He; Xingyu Yang; Weiwei Cheng

doi:10.1016/j.heliyon.2024.e29225

Identification of shared gene signatures and biological mechanisms between preeclampsia and polycystic ovary syndrome

Heliyon. 2024 Apr 4;10(8):e29225. doi: 10.1016/j.heliyon.2024.e29225. eCollection 2024 Apr 30.

Authors

Yaoxi Xiong^{1

2}, Chao Chen^{1

2}, Chengrong He^{1

2}, Xingyu Yang^{1

2}, Weiwei Cheng¹

Affiliations

¹ International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, 200030, Shanghai, China.
² Shanghai Key Laboratory of Embryo Original Disease, 200030, Shanghai, China.

Abstract

Preeclampsia (PE) is one of the most common complications of pregnancy and polycystic ovary syndrome (PCOS) is a prevalent metabolic and endocrinopathy disorder in women of reproductive age. Identifying the shared genetic signatures and molecular mechanisms between PCOS and PE was the objective of this study. The intersections of WGCNA module genes, PPI module genes, and PPI hub genes revealed that 8 immunity-related genes might be shared causative genes of PE and PCOS. Further, qRT-PCR results showed that TSIX/miR-223-3p/DDX58 might play a crucial role in immune dysregulation in PE and PCOS and Spearman rank correlation analysis results illustrated the potential of DDX58 as a novel diagnostic and therapeutic target for PE and PCOS. Our study demonstrated a common disease pathway model TSIX/miR-223-3p/DDX58, illustrating that immune dysregulation may be a possible mechanism of PE and PCOS, and revealed that DDX58 might be a novel predictive target for PE and PCOS.

Keywords: Bioinformatics; DDX58; Polycystic ovary syndrome; Preeclampsia; WGCNA.